What Are the Signs of Insulin Resistance | MetaGO

Insulin Resistance Explained: The Test, the Signs, the Fix

Table of Contents

Quick Answer
Insulin resistance means your muscle, liver and fat cells stop responding well to insulin, so the pancreas makes more to keep blood sugar normal. Most people feel nothing for years. HOMA-IR can hint at it early; HbA1c and fasting glucose show whether it has become prediabetes. Weight loss, strength training and fewer refined carbs can reverse it.

What Is Insulin Resistance?

Insulin resistance is a state in which your cells respond weakly to insulin, the hormone that moves sugar out of the blood and into muscle, liver and fat. Blood sugar can stay perfectly normal for years while this is happening, which is exactly why it goes unnoticed.

How insulin normally works

You eat a plate of rice and dal. The starch breaks down into glucose, your blood sugar rises, and the pancreas releases insulin in response.

Insulin travels to your muscles, liver and fat tissue and tells them to absorb that glucose.

What goes wrong

In insulin resistance, those cells stop listening properly. Muscle pulls in less glucose, the liver keeps releasing sugar when it should pause, and fat cells leak more fatty acids into the blood.

The pancreas compensates by producing extra insulin. Doctors call this high-insulin phase hyperinsulinaemia, and it can last for years.

Trouble begins when the insulin-making beta cells in the pancreas can no longer keep up. Glucose then creeps up, first into the prediabetes range and later, for some people, into type 2 diabetes.

Visceral fat, the deep belly fat packed against the liver and gut, is one of the strongest drivers of this whole process.

Why Indians Are More Prone to Insulin Resistance

Indians tend to develop insulin resistance at lower body weights than Europeans. Researchers call this the thin-fat phenotype: a body that looks slim on the scale but carries more fat, and less muscle, than its BMI suggests.

The Y-Y paradox showed two doctors, one from Pune and one from London, with near-identical BMIs. Their body scans told a different story: the Indian doctor carried substantially more body fat.

That extra fat tends to settle in the belly. In a study by Raji and colleagues in the Journal of Clinical Endocrinology and Metabolism (2001), healthy Asian Indians matched to Caucasians for age and BMI had more abdominal and visceral fat, and already showed markers of insulin resistance.

This is why Indian thresholds are lower. The Revised definition of obesity in Asian Indians living in India (Misra et al., 2025) treats a BMI above 23 as the starting point for obesity, and uses a waist of 90 cm in men or 80 cm in women as the marker of risky belly fat.

The ICMR-INDIAB national study, published in The Lancet Diabetes and Endocrinology in 2023, estimated 101 million Indian adults living with diabetes, another 136 million with prediabetes, and 351 million with abdominal obesity.

A 2025 ICMR-INDIAB dietary analysis in Nature Medicine found Indians get about 62% of their daily calories from carbohydrates, largely from white rice, milled flour and added sugar, while protein averages only about 12%.

Signs and Symptoms of Insulin Resistance

Insulin resistance has no symptom that belongs to it alone. Most people discover it on a blood report rather than in the mirror.

Acanthosis nigricans, waist size, fatigue and cravings

Acanthosis nigricans is the most visible clue: darker, velvety, slightly thickened skin on the back of the neck, in the armpits or over the knuckles.

High insulin levels stimulate extra growth of skin cells, which is why the StatPearls clinical review of acanthosis nigricans lists insulin resistance and diabetes as its most common associations.

Your waist is the next clue, and for Indians it says more than your weight. A tape measure reading at or above 90 cm in men or 80 cm in women points to the abdominal fat pattern that fuels insulin resistance, even when BMI looks fine.

Then come the vaguer signs. Heavy drowsiness after a carb-rich lunch, a strong pull towards something sweet after meals, small skin tags on the neck, and in women, irregular periods linked to PCOS. None of these proves insulin resistance alone, but a cluster of them deserves a blood test.

Routine reports can hint as well. High triglycerides with low HDL cholesterol, or a fatty liver noted on an abdominal ultrasound, often travel with insulin resistance.

How Insulin Resistance Is Diagnosed

Here is the part most articles skip: no single blood test officially diagnoses insulin resistance. Doctors piece it together from glucose tests, insulin levels, waist size and your family history.

Fasting insulin and HOMA-IR

HOMA-IR estimates insulin resistance from one fasting blood sample. The formula is simple: fasting insulin (µU/mL) × fasting glucose (mg/dL) ÷ 405. A higher number means more resistance.

The model’s own developers, in Use and abuse of HOMA modeling (Wallace, Levy and Matthews, 2004), describe it as best suited to research and population studies. There is no universally agreed cut-off, and insulin assays differ between labs, so the same number from two labs may not mean the same thing.

Treat HOMA-IR as an early warning light, not a verdict.

HbA1c normal range and fasting glucose

HbA1c reflects your average blood sugar over the past two to three months. Read together, they show whether insulin resistance has already started pushing sugar up.

TestNormalPrediabetesDiabetes
HbA1cBelow 5.7%5.7% to 6.4%6.5% or higher
Fasting plasma glucoseBelow 100 mg/dL100 to 125 mg/dL126 mg/dL or higher
2-hour glucose (75 g OGTT)Below 140 mg/dL140 to 199 mg/dL200 mg/dL or higher

Source: ADA Standards of Care in Diabetes 2026, Diagnosis and Classification. The WHO sets impaired fasting glucose at 110 to 125 mg/dL, so some Indian labs report a slightly different prediabetes range.

One Indian-specific caveat matters here. Iron deficiency, common in India and especially among women, can push HbA1c up without any real rise in blood sugar, according to a systematic review in Diabetologia by English and colleagues (2015). If your HbA1c and fasting glucose disagree, ask your doctor to check haemoglobin and iron levels.

Start with HbA1c and fasting glucose, the standard screening pair. If those look normal but your risk is high, a fasting insulin for HOMA-IR adds an early signal, and an oral glucose tolerance test can catch after-meal spikes the other two miss.

Insulin Resistance vs Prediabetes vs Type 2 Diabetes

These are three stops on one road, not three separate diseases.

Insulin resistance comes first. Glucose is normal, insulin is high, and the pancreas is working overtime to hold the line.

Prediabetes means the pancreas is starting to lose that battle: an HbA1c of 5.7% to 6.4%, or fasting glucose between 100 and 125 mg/dL. Type 2 diabetes begins once HbA1c reaches 6.5% or fasting glucose reaches 126 mg/dL.

Indians tend to travel this road quickly. In Natural History of Type 2 Diabetes in Indians (Narayan et al., Diabetes Care, 2024), people with impaired glucose tolerance progressed to diabetes at 13.9% a year, and those with isolated high fasting glucose at 8.6% a year.

How to Reverse Insulin Resistance

The Indian Diabetes Prevention Programme (Ramachandran et al., Diabetologia, 2006) followed Indians with impaired glucose tolerance. Moderate, consistent lifestyle changes lowered their risk of developing diabetes by 28.5% over three years.

Weight loss: how much is enough

Less than most people assume. The Diabetes Prevention Program trial (Knowler et al., NEJM, 2002) set a goal of losing 7% of body weight and combined it with 150 minutes of weekly activity. That cut the risk of diabetes by 58%.

Bigger losses do more. In the DiRECT trial (Lean et al., The Lancet, 2018), 86% of people with type 2 diabetes who lost 15 kg or more were in remission a year later.

Diet: low-GI Indian swaps

The ICMR-INDIAB dietary analysis carries a surprise worth knowing: swapping white rice for whole wheat or millet flour, without eating less of it overall, was not linked with lower diabetes risk. Total carbohydrate was what counted.

Protein made the difference. In the same data, replacing just 5% of daily calories from carbohydrates with plant or dairy protein was linked with a lower risk of diabetes and prediabetes.

The ICMR-NIN Dietary Guidelines for Indians 2024 point the same way. They suggest cereals supply no more than 45% of daily calories, that at least half of those cereals be whole grains, and that added sugar stays under 5% of energy.

A few everyday swaps cover most of the ground. Let sabzi and salad take up half the thali and keep rice or roti to a quarter. Add an extra katori of dal, chana, rajma, paneer or curd to lunch and dinner. Pick a moong dal chilla or besan cheela over a second helping of poha or white bread at breakfast, and taper the sugar in your chai.

These are general swaps, not a meal plan. If you have diabetes, kidney disease or take glucose-lowering medicine, a registered dietitian should set your portions.

Strength training and walking after meals

Muscle soaks up more blood glucose than any other tissue, so building it pays off. The American Diabetes Association position statement on physical activity (Colberg et al., 2016) recommends resistance training two to three times a week on non-consecutive days, alongside regular aerobic activity.

Timing helps too. In a randomised crossover trial by Reynolds and colleagues in Diabetologia (2016), a 10-minute walk after each main meal lowered post-meal blood sugar by 12% more than one 30-minute walk at another time. The biggest effect came after dinner, the most carb-heavy meal of the day.

Sleep and stress

Poor sleep makes insulin work less efficiently. In a classic Lancet study by Spiegel and colleagues (1999), healthy young men limited to four hours of sleep a night for six nights showed clearly worse glucose tolerance.

Long-term stress pushes in the same direction through cortisol, a hormone that raises blood sugar. Loud snoring with daytime sleepiness also deserves a check for sleep apnoea, which often travels with insulin resistance.

Medication: Metformin and GLP-1s

Metformin is the longest-used option. It mainly reduces the glucose your liver releases and modestly improves insulin sensitivity. In the Indian Diabetes Prevention Programme it lowered the risk of diabetes by 26.4%, close to the effect of lifestyle change.

GLP-1 medicines work differently. They mimic a gut hormone that boosts insulin release after meals, slows stomach emptying and dampens appetite, so people eat less and lose weight, especially from the belly. That fat loss is what eases insulin resistance.

In clinical trials, people taking these medicines lost up to 20% of their body weight. The SURMOUNT-1 trial (Jastreboff et al., NEJM, 2022) also tracked blood sugar and found clear improvements in participants who started with prediabetes, compared with placebo.

These are prescription medicines. They are not suitable for everyone, they can cause side effects such as nausea, and they work best alongside the food and activity changes above. Whether metformin or a GLP-1 medicine fits you is a decision to make with your doctor, under ongoing medical supervision.

When to See a Doctor

Book a check-up if your waist is at or above 90 cm (men) or 80 cm (women), you notice dark velvety skin on your neck or armpits, a parent or sibling has type 2 diabetes, you had diabetes during pregnancy, you have Insulin resistance can stay silent for years with normal blood sugar, and in Indians it often appears at a BMI above 23 or a waist of 90 cm (men) and 80 cm (women).

  • No single test diagnoses it. HbA1c and fasting glucose show whether it has reached prediabetes; HOMA-IR can flag it earlier but has no agreed cut-off.
  • Indian data shows that cutting total carbohydrates and adding protein matters more than simply swapping rice for millets.
  • Modest weight loss, strength training, a walk after meals and better sleep can reverse it for many people.
  • Metformin and GLP-1 medicines can help some people, always under a doctor’s supervision.

PCOS, or your triglycerides or liver tests come back high.

Go sooner if you have constant thirst, frequent urination, blurred vision or unexplained weight loss.

Conclusion
Insulin resistance can stay silent for years with normal blood sugar, and in Indians it often appears at a BMI above 23 or a waist of 90 cm (men) and 80 cm (women). No single test diagnoses it. HbA1c and fasting glucose show whether it has reached prediabetes; HOMA-IR can flag it earlier but has no agreed cut-off. Indian data shows that cutting total carbohydrates and adding protein matters more than simply swapping rice for millets. Modest weight loss, strength training, a walk after meals and better sleep can reverse it for many people. Metformin and GLP-1 medicines can help some people, always under a doctor’s supervision.

Frequently Asked Questions

1. What are the symptoms of insulin resistance?

Most people have none for years. Visible clues include dark, velvety skin on the neck or armpits (acanthosis nigricans), a waist at or above 90 cm in men or 80 cm in women, skin tags, drowsiness after carb-heavy meals, sugar cravings and, in women, irregular periods linked to PCOS.

2. Which blood test detects it?

No single test officially diagnoses insulin resistance. HOMA-IR, calculated from fasting insulin and fasting glucose, estimates it directly but has no universal cut-off. HbA1c and fasting glucose show whether it has progressed to prediabetes or diabetes.

3. Can insulin resistance be reversed?

Yes, often. Losing even 5% to 7% of body weight, strength training, walking after meals, better sleep and fewer refined carbohydrates improve insulin sensitivity for many people.

4. What diet helps most?

A diet lower in total carbohydrates and higher in protein and fibre. Indian data suggests that eating less rice, roti and sugar overall, and adding dal, chana, paneer, curd and vegetables, matters more than switching to millets alone. A registered dietitian can personalise portions.

5. Does insulin resistance always lead to diabetes?

No. Many people with insulin resistance never develop type 2 diabetes because their pancreas keeps up with the extra demand. The risk rises with age, belly fat, family history and inactivity, and acting early lowers it substantially.

Medical Disclaimer
This article is for general education and is not a substitute for medical advice, diagnosis or treatment. Speak to a qualified doctor before starting, stopping or changing any medicine, diet or exercise routine, especially if you have diabetes or another health condition.
  1. Anjana RM, et al. Metabolic non-communicable disease health report of India: the ICMR-INDIAB national cross-sectional study (ICMR-INDIAB-17). Lancet Diabetes Endocrinol. 2023;11(7):474–489. https://doi.org/10.1016/S2213-8587(23)00119-5
  2. Anjana RM, Sudha V, et al. Dietary profiles and associated metabolic risk factors in India from the ICMR-INDIAB survey-21. Nat Med. 2025. https://doi.org/10.1038/s41591-025-03949-4
  3. Misra A, Vikram NK, Ghosh A, Ranjan P, Gulati S. Revised definition of obesity in Asian Indians living in India. Diabetes Metab Syndr. 2025;19(1):102989. https://doi.org/10.1016/j.dsx.2024.102989
  4. Yajnik CS, Yudkin JS. The Y-Y paradox. Lancet. 2004;363(9403):163. https://doi.org/10.1016/S0140-6736(03)15269-5
  5. Raji A, Seely EW, Arky RA, Simonson DC. Body fat distribution and insulin resistance in healthy Asian Indians and Caucasians. J Clin Endocrinol Metab. 2001;86(11):5366–5371. https://doi.org/10.1210/jcem.86.11.7992
  6. Acanthosis Nigricans. StatPearls. NCBI Bookshelf. https://www.ncbi.nlm.nih.gov/books/NBK431057/
  7. Wallace TM, Levy JC, Matthews DR. Use and abuse of HOMA modeling. Diabetes Care. 2004;27(6):1487–1495. https://doi.org/10.2337/diacare.27.6.1487
  8. American Diabetes Association Professional Practice Committee. Diagnosis and Classification of Diabetes: Standards of Care in Diabetes 2026. Diabetes Care. 2026. https://doi.org/10.2337/dc26-S002
  9. English E, Idris I, Smith G, Dhatariya K, Kilpatrick ES, John WG. The effect of anaemia and abnormalities of erythrocyte indices on HbA1c analysis: a systematic review. Diabetologia. 2015;58(7). https://doi.org/10.1007/s00125-015-3599-3
  10. Narayan KMV, Kondal D, Chang HH, et al. Natural history of type 2 diabetes in Indians: time to progression. Diabetes Care. 2024;47(5):858–863. https://doi.org/10.2337/dc23-1514
  11. Ramachandran A, Snehalatha C, Mary S, Mukesh B, Bhaskar AD, Vijay V. The Indian Diabetes Prevention Programme shows that lifestyle modification and metformin prevent type 2 diabetes in Asian Indian subjects with impaired glucose tolerance (IDPP-1). Diabetologia. 2006;49(2):289–297. https://doi.org/10.1007/s00125-005-0097-z
  12. Knowler WC, et al. Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin. N Engl J Med. 2002;346(6):393–403. https://doi.org/10.1056/NEJMoa012512
  13. Lean MEJ, et al. Primary care-led weight management for remission of type 2 diabetes (DiRECT): an open-label, cluster-randomised trial. Lancet. 2018;391(10120):541–551. https://doi.org/10.1016/S0140-6736(17)33102-1
  14. ICMR-NIN Expert Committee. Dietary Guidelines for Indians 2024. ICMR-National Institute of Nutrition, Hyderabad. https://nin.res.in/dietaryguidelines/pdfjs/locale/DGI_2024.pdf
  15. Colberg SR, et al. Physical activity/exercise and diabetes: a position statement of the American Diabetes Association. Diabetes Care. 2016;39(11):2065–2079. https://doi.org/10.2337/dc16-1728
  16. Reynolds AN, Mann JI, Williams S, Venn BJ. Advice to walk after meals is more effective for lowering postprandial glycaemia in type 2 diabetes mellitus than advice that does not specify timing: a randomised crossover study. Diabetologia. 2016;59(12):2572–2578. https://pubmed.ncbi.nlm.nih.gov/27747394/
  17. Spiegel K, Leproult R, Van Cauter E. Impact of sleep debt on metabolic and endocrine function. Lancet. 1999;354(9188):1435–1439. https://doi.org/10.1016/S0140-6736(99)01376-8
  18. Jastreboff AM, et al. SURMOUNT-1 trial. N Engl J Med. 2022;387(3):205–216. https://doi.org/10.1056/NEJMoa2206038
Picture of Dr. Abhinav Garg

Dr. Abhinav Garg

MBBS, MD (Internal Medicine), [Expert Doctor, 10+ years of experience in obesity care Treated 240+ patients with GLP-1 medications]